CNTO-6785 is a humanized monoclonal antibody inhibitor that targets interleukin-17A (IL-17A). It holds potential for research in chronic obstructive pulmonary disease (COPD).
Target:
Interleukin
* VAT and and shipping costs not included. Errors and price changes excepted
